[1] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[2] |
LI Youjia, XIE Jiao, JI Cheng, YAO Hongyi.
Amounts of Tyrosine Kinase Inhibitors Used in Hospitals in Nanjing from 2017 to 2019
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 743-747.
|
[3] |
HE Xuan, WANG Xiao, DAI Huizhen, LI Xin, HAN Feng.
Usage of New Anti-cancer Drugs in Nanjing from 2018 to 2020
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 725-730.
|
[4] |
CAI Jiangxia, AN Linna.
Pharmacological Practice for One Case of Advanced Lung Cancer with Bronchial Asthma and Pulmonary Infection
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(8): 492-495.
|
[5] |
FAN Ying-ying, QI Ying-ying, MU Xing-jia, WANG Chen-hui, JIANG Qing-dan, QIAO Ming-juan.
Suggestions on Improvement of Administrative Regulations on Narcotic Drugs and Psychotropic Drugs in China
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(1): 28-31.
|
[6] |
WU Nan, ZHANG Dong-lei, WANG Lei, DING Nian-yang, LI Jie YANG, Yang YAN, Dan TONG, Ben-ding, WEI Qing.
Study on the Correlation between G211T Mutation and the Efficacy and Safety of Morphine Treatment on Cancer Pain
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(1): 14-18.
|
[7] |
WEI Ning, PAN Hong-mei, LIAO Yi.
Narcotic Drugs and Psychotropic Drugs of Category 1 Management Research Based on the PDCA Cycle
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(8): 500-502.
|
[8] |
LIU Xiao-yan.
Pharmaceutical Care of a Case of Advanced Esophageal Cancer by Clinical Pharmacists
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(4): 249-251.
|
[9] |
ZHANG Dong-lei, WEI Qing, Tong Ben-ding, Wu Nan, Ding Xuan-sheng.
Pharmaceutical Care of Clinical Pharmacists on a Cancer Patient with Severe Pain
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(4): 245-247.
|
[10] |
YU Li-hua, LIU Meng-juan, WANG Zeng.
Research Progress of Opioid Preparations in Cancer Pain Treatment
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(1): 19-22.
|
[11] |
WANG Yu-ping.
Application Analysis on the Second Class Psychotropic Drugs in Our Hospital from 2009 to 2011
[J]. Chinese Journal of Pharmacovigilance, 2012, 9(8): 500-502.
|
[12] |
HU Wen-Jun, ZHOU Li-Qiong, HUANG Wen-Tao, QIN Shao-Jin.
Application of Narcotics Analgesic in Our Hospital from 2008 to 2010
[J]. Chinese Journal of Pharmacovigilance, 2012, 9(1): 35-37.
|
[13] |
WANG Li, JIA Jia, LIU Chang, HAN Chun-hong, YU Zhong-he, LIU Duan-qi.
Analysis of Adverse Effects of Opioids in Moderate to Severe Cancer Pain of Elderly Patients
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(9): 553-554.
|
[14] |
LIN Zhi-qiang, ZHANG Guo-wei, WANG Da-xuan, FU Xin-yang, GONG Hai-hong.
The Relationship Between Antimicrobial Consumption and Rates of Bacterial Resistance
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(2): 75-80.
|
[15] |
LIU Wei, LUAN Rong, ZHAI Suo-di.
Comparison of the Drug Package Inserts of Domestic and Foreign Compound Preparations Containing Narcotic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(10): 603-605.
|